Cell line · CVCL_1102
Ca9-22
Cancer cell line, Homo sapiens. Gingival squamous cell carcinoma. Cellosaurus records it as partially contaminated. 35 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. Ca9-22. Cell lines, record CVCL_1102. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1102
On this page
Cell line
As Cellosaurus gives it.
- Name
- Ca9-22
- Accession
- CVCL_1102
- RRID
- RRID:CVCL_1102
- Synonyms
- CA9-22, Ca 9-22, CA922, Ca922
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 43Y
- Category
- Cancer cell line
- Diseases
- Gingival squamous cell carcinoma (NCIt C129857); Squamous cell carcinoma of the oral cavity (ORDO Orphanet_502363)
- Derived from
- Oral cavity, gingiva (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems1
| Problem | Cellosaurus's note |
|---|---|
| Partially contaminated | Some stocks of Ca9-22 are contaminated with MSK-922 (PubMed=21868764). |
Source Cellosaurus
Papers35
1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| SLC15A4 promotes oral cancer progression by regulating TLR9 and activating the JAK/STAT signaling pathway. | Head Face Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Evaluation of the Antifungal Activity of the Polyphenol Formulation Viroelixir Against Candida albicans. | Antibiotics (Basel) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Distinct Regulation of the ARF and TAp73 Tumor Suppressor Genes by the Transcription Factor E2F1 Enables Discrimination of Cancer Cells from Normal Growing Cells. | Cells | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Repurposing Antimalarials for Oral Cancer: Selective Efficacy of Hydroxychloroquine on Gingival Squamous Cell Carcinoma. | Int J Mol Sci | 2025 | Its Methods give the RRID and name the line | PubMed | |
| New Curcumin Analogue (PAC) Inhibits Candida albicans Virulence, Restricts Its Adhesion Potential, and Relieves Oral Epithelial Cell Inflammation and Defense Mechanisms. | Antibiotics (Basel) | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Eugenol as a potential adjuvant therapy for gingival squamous cell carcinoma. | Sci Rep | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Pan-cancer proteomic map of 949 human cell lines. | Cancer Cell | 2022 | Cellosaurus cites it | PubMed | |
| Crosstalk between oral squamous cell carcinoma cells and cancer-associated fibroblasts via the TGF-β/SOX9 axis in cancer progression. | Transl Oncol | 2021 | Its Methods give the RRID and name the line | PubMed | |
| DDX3 modulates the tumor microenvironment via its role in endoplasmic reticulum-associated translation. | iScience | 2021 | Its Methods give the RRID and name the line | PubMed | |
| Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens. | Nature | 2019 | Cellosaurus cites it | PubMed |
1 to 10 of 35
See all 35 papersRelatives3
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | Ca9-22PF | CVCL_HM42 | Cell lines | |
| Derived from it | Ca9-22SF | CVCL_HM41 | Cell lines | |
| Derived from it | KOSC-3 | CVCL_2789 | Has a recorded problem | Cell lines |
Cell banks3
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| JCRB | JCRB0625 | JCRB | |
| RCB | RCB1976 | RCB | |
| TKG | TKG 0485 | Cellosaurus |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1102
GET https://conductscience.org/api/cell-lines/v1/CVCL_1102/papers?page=2